Loading...
 
Toggle Health Problems and D

Vitamin D and Cancer - Jan 2024


Vitamin D and potential effects on cancers: a review

Mol Biol Rep. 2024 Jan 25;51(1):190. doi: 10.1007/s11033-023-09111-y
PDF is behind a paywall. Can be viewed at DeepDyve
Pouria Sobhi 1, Mohammad Bahrami 1, Faraz Mahdizadeh 1, Aliakbar Fazaeli 2, Ghader Babaei 3, Lotfollah Rezagholizadeh 4

Vitamin D is common to 4 concerns
Image
Cancer is characterized by the abnormal and uncontrollable division and growth of cells that can infiltrate tissues and alter normal physiological function, which will become crucial and life-threatening if left untreated. Cancer can be a result of genetics, such as mutations or environmental causes, including smoking, lack of physical activity, as well as nutritional imbalance in the body. Vitamin D is one of the foremost nutrients that play a crucial role in a variety of biochemical pathways, and it is an important key factor in several diseases. Vitamin D is an essential nutrient for preventing malignancies and a complementary treatment for cancer through direct and indirect biochemical pathways. In this article, we summarized the correlation between vitamin D and various cancers using an extensive search on PubMed, Google Scholar, and Scopus. This paper reviews the role of vitamin D in different types of cancer.


99 References
  1. Christakos S et al (2010) Vitamin D: metabolism. Endocrinol Metab Clin North Am 39(2):243–253 (table of contents) - PubMed - PMC - DOI
  2. Carlberg C (2019) Vitamin D: a micronutrient regulating genes. Curr Pharm Des 25(15):1740–1746 - PubMed - DOI
  3. Wang Y, Zhu J, DeLuca HF (2012) Where is the vitamin D receptor? Arch Biochem Biophys 523(1):123–133 - PubMed - DOI
  4. Akimbekov NS et al (2022) Vitamin D and phosphate interactions in health and disease. Adv Exp Med Biol 1362:37–46 - PubMed - DOI
  5. Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930 - PubMed - DOI
  6. Chang EM et al (2014) Association between sex steroids, ovarian reserve, and vitamin D levels in healthy nonobese women. J Clin Endocrinol Metab 99(7):2526–2532 - PubMed - DOI
  7. Zanatta L et al (2011) Nongenomic and genomic effects of 1alpha,25(OH)2 vitamin D3 in rat testis. Life Sci 89(15–16):515–523 - PubMed - DOI
  8. Zhao D et al (2017) Serum vitamin D and sex hormones levels in men and women: the Multi-Ethnic Study of Atherosclerosis (MESA). Maturitas 96:95–102 - PubMed - DOI
  9. Bergengren O et al (2023) 2022 update on prostate cancer epidemiology and risk factors—a systematic review. Eur Urol 84(2):191–206 - PubMed - DOI
  10. Song ZY et al (2018) Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis. Endocr Connect 7(12):R294–R303 - PubMed - PMC - DOI
  11. Capiod T et al (2018) Do dietary calcium and vitamin D matter in men with prostate cancer? Nat Rev Urol 15(7):453–461 - PubMed - DOI
  12. Bao BY, Yeh SD, Lee YF (2006) 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases. Carcinogenesis 27(1):32–42 - PubMed - DOI
  13. Woo TC et al (2005) Pilot study: potential role of vitamin D (Cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr cancer 51(1):32–36 - PubMed - DOI
  14. Bernichtein S et al (2017) Vitamin D3 prevents calcium-induced progression of early-stage prostate tumors by counteracting TRPC6 and calcium sensing receptor upregulation. cancer Res 77(2):355–365 - PubMed - DOI
  15. Barreto AM et al (2000) 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. cancer Epidemiol Biomarkers Prev 9(3):265–270 - PubMed
  16. Gupta D et al (2009) Vitamin D and prostate cancer risk: a review of the epidemiological literature. Prostate cancer Prostatic Dis 12(3):215–226 - PubMed - DOI
  17. Tuohimaa P et al (2004) Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J cancer 108(1):104–108 - PubMed - DOI
  18. Gao J et al (2018) Circulating vitamin D concentration and risk of prostate cancer: a dose-response meta-analysis of prospective studies. Ther Clin Risk Manag 14:95–104 - PubMed - PMC - DOI
  19. Wilkinson L, Gathani T (2022) Understanding breast cancer as a global health concern. Br J Radiol 95(1130):20211033 - PubMed - DOI
  20. Mittal MK et al (2008) In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun 372(1):30–34 - PubMed - PMC - DOI
  21. Liu X et al (2018) miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer. Oncogene 37(25):3426–3439 - PubMed - DOI
  22. Larriba MJ, Garcia de Herreros A, Munoz A (2016) Vitamin D and the epithelial to mesenchymal transition. Stem Cells Int 2016:6213872 - PubMed - PMC - DOI
  23. Lopes N et al (2012) 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation. Anticancer Res 32(1):249–257 - PubMed
  24. Wilmanski T et al (2016) 1alpha,25-dihydroxyvitamin D inhibits the metastatic capability of MCF10CA1a and MDA-MB-231 cells in an in vitro model of breast to bone metastasis. Nutr cancer 68(7):1202–1209 - PubMed - PMC - DOI
  25. Koli K, Keski-Oja J (2000) 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 11(4):221–229 - PubMed
  26. Li J et al (2021) Vitamin D regulates CXCL12/CXCR4 and epithelial-to-mesenchymal transition in a model of breast cancer metastasis to lung. Endocrinology. https://doi.org/10.1210/endocr/bqab049 - DOI - PubMed - PMC
  27. Anisiewicz A et al (2018) Unfavorable effect of calcitriol and its low-calcemic analogs on metastasis of 4T1 mouse mammary gland cancer. Int J Oncol 52(1):103–126 - PubMed
  28. Anisiewicz A et al (2019) Calcitriol analogues decrease lung metastasis but impair bone metabolism in aged ovariectomized mice bearing 4T1 mammary gland tumours. Aging Dis 10(5):977–991 - PubMed - PMC - DOI
  29. Vanhevel J et al (2022) The role of vitamin D in breast cancer risk and progression. Endocr Relat cancer 29(2):R33–R55 - PubMed - DOI
  30. Filip-Psurska B et al (2022) Vitamin D, Th17 lymphocytes, and breast cancer. cancers 14(15):3649 - PubMed - PMC - DOI
  31. Krishnan AV et al (2010) Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 151(1):32–42 - PubMed - DOI
  32. Swami S et al (2011) Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo. Horm cancer 2(3):190–202 - PubMed - PMC - DOI
  33. Vink-van Wijngaarden T et al (1994) Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen. cancer Res 54(21):5711–5717 - PubMed
  34. Lim ST et al (2018) Synergistic anticancer effects of ruxolitinib and calcitriol in estrogen receptor-positive, human epidermal growth factor receptor 2-positive breast cancer cells. Mol Med Rep 17(4):5581–5588 - PubMed - PMC
  35. Friedrich M et al (2018) Effects of combined treatment with vitamin D and COX2 inhibitors on breast cancer cell lines. Anticancer Res 38(2):1201–1207 - PubMed
  36. Segovia-Mendoza M et al (2017) The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast cancer cells. Am J cancer Res 7(7):1486–1500 - PubMed - PMC
  37. Tavera-Mendoza LE et al (2017) Vitamin D receptor regulates autophagy in the normal mammary gland and in luminal breast cancer cells. Proc Natl Acad Sci USA 114(11):E2186–E2194 - PubMed - PMC - DOI
  38. Estebanez N et al (2018) Vitamin D exposure and Risk of Breast cancer: a meta-analysis. Sci Rep 8(1):9039 - PubMed - PMC - DOI
  39. Song D et al (2019) Vitamin D intake, blood vitamin D levels, and the risk of breast cancer: a dose-response meta-analysis of observational studies. Aging 11(24):12708–12732 - PubMed - PMC - DOI
  40. Vaughan-Shaw PG et al (2017) The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis. Br J cancer 116(8):1092–1110 - PubMed - PMC - DOI
  41. Hossain S et al (2019) Vitamin D and breast cancer: a systematic review and meta-analysis of observational studies. Clin Nutr ESPEN 30:170–184 - PubMed - PMC - DOI
  42. Crew KD et al (2019) Randomized double-blind placebo-controlled biomarker modulation study of vitamin D supplementation in premenopausal women at high risk for breast cancer (SWOG S0812). cancer Prev Res 12(7):481–490 - DOI
  43. Crew KD et al (2009) Association between plasma 25-hydroxyvitamin D and breast cancer risk. cancer Prev Res 2(6):598–604 - DOI
  44. Qin B et al (2020) Intake of vitamin D and calcium, sun exposure, and risk of breast cancer subtypes among black women. Am J Clin Nutr 111(2):396–405 - PubMed - DOI
  45. Manson JE et al (2019) Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 380(1):33–44 - PubMed - DOI
  46. Chandler PD et al (2020) Effect of vitamin D3 supplements on development of advanced cancer: a secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open 3(11):e2025850 - PubMed - PMC - DOI
  47. Lappe J et al (2017) Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial. JAMA 317(12):1234–1243 - PubMed - DOI
  48. Scragg RKR (2019) Overview of results from the Vitamin D assessment (ViDA) study. J Endocrinol Investig 42(12):1391–1399 - DOI
  49. Arnaout A et al (2019) Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients. Breast cancer Res Treat 178(2):347–356 - PubMed - DOI
  50. Li Z et al (2021) Effect of vitamin D supplementation on risk of breast cancer: a systematic review and meta-analysis of randomized controlled trials. Front Nutr 8:655727 - PubMed - PMC - DOI
  51. Voutsadakis IA (2021) Vitamin D baseline levels at diagnosis of breast cancer: A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 14(1):16–26 - PubMed - DOI
  52. O’Brien KM et al (2018) Vitamin D, DNA methylation, and breast cancer. Breast cancer Res 20(1):70 - PubMed - PMC - DOI
  53. Simmons KM et al (2015) Gene signatures of 1,25-dihydroxyvitamin D3 exposure in normal and transformed mammary cells. J Cell Biochem 116(8):1693–1711 - PubMed - PMC - DOI
  54. O’Brien KM et al (2022) Vitamin D supplement use and risk of breast cancer by race-ethnicity. Epidemiology 33(1):37–47 - PubMed - PMC - DOI
  55. Sheng L, Callen DF, Turner AG (2018) Vitamin D(3) signaling and breast cancer: insights from transgenic mouse models. J Steroid Biochem Mol Biol 178:348–353 - PubMed - DOI
  56. Bauer SR et al (2013) Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine 92(3):123–131 - PubMed - PMC - DOI
  57. Lewandowska A et al (2022) Risk factors for the diagnosis of colorectal cancer. Cancer Control 29:10732748211056692 - PubMed - PMC - DOI
  58. Klampfer L (2014) Vitamin D and colon cancer. World J Gastrointest Oncol 6(11):430–437 - PubMed - PMC - DOI
  59. Ferrer-Mayorga G et al (2019) Mechanisms of action of vitamin D in colon cancer. J Steroid Biochem Mol Biol 185:1–6 - PubMed - DOI
  60. Khayami R et al (2022) Epigenomic effects of vitamin D in colorectal cancer. Epigenomics 14(19):1213–1228 - PubMed - DOI
  61. Huang CY et al (2022) Bioactive vitamin D attenuates MED28-mediated cell growth and epithelial-mesenchymal transition in human colorectal cancer cells. Biomed Res Int 2022:2268818 - PubMed - PMC - DOI
  62. Varghese JE (2020) Role of vitamin D3 on apoptosis and inflammatory-associated gene in colorectal cancer: an in vitro approach. J King Saud Univ Sci 32(6):2786–2789 - DOI
  63. Lamprecht SA, Lipkin M (2003) Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev cancer 3(8):601–614 - PubMed - DOI
  64. Timar J, Ladanyi A (2022) Molecular pathology of skin melanoma: epidemiology, differential diagnostics, prognosis and therapy prediction. Int J Mol Sci 23(10):5384 - PubMed - PMC - DOI
  65. Branisteanu DE et al (2023) Differences and similarities in epidemiology and risk factors for cutaneous and uveal melanoma. Medicina 59(5):943 - PubMed - PMC - DOI
  66. Zhou M et al (2016) Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet 387(10015):251–272 - PubMed - DOI
  67. Veierod MB et al (2010) Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. cancer Epidemiol Biomarkers Prev 19(1):111–120 - PubMed - DOI
  68. Gajos-Michniewicz A, Czyz M (2020) WNT signaling in melanoma. Int J Mol Sci 21(14):4852 - PubMed - PMC - DOI
  69. Holstein TW (2012) The evolution of the Wnt pathway. Cold Spring Harb Perspect Biol 4(7):a007922 - PubMed - PMC - DOI
  70. Chaiprasongsuk A et al (2019) Protective effects of novel derivatives of vitamin D(3) and lumisterol against UVB-induced damage in human keratinocytes involve activation of Nrf2 and p53 defense mechanisms. Redox Biol 24:101206 - PubMed - PMC - DOI
  71. Liyanage UE et al (2020) Is there a causal relationship between vitamin D and melanoma risk? A Mendelian randomization study. Br J Dermatol 182(1):97–103 - PubMed - DOI
  72. Millen AE et al (2004) Diet and melanoma in a case-control study. cancer Epidemiol Biomark Prev 13(6):1042–1051 - DOI
  73. van der Pols JC et al (2013) Vitamin D status and skin cancer risk independent of time outdoors: 11-year prospective study in an Australian community. J Investig Dermatol 133(3):637–641 - PubMed - DOI
  74. Saiag P et al (2015) Prognostic value of 25-hydroxyvitamin D3 levels at diagnosis and during follow-up in melanoma patients. J Natl cancer Inst 107(12):djv264 - PubMed - DOI
  75. Muralidhar S et al (2019) Vitamin D-VDR signaling inhibits Wnt/β-catenin-mediated melanoma progression and promotes antitumor immunity. cancer Res 79(23):5986–5998 - PubMed - DOI
  76. Becker AL et al (2021) The role of the vitamin D receptor in the pathogenesis, prognosis, and treatment of cutaneous melanoma. Front Oncol 11:743667 - PubMed - PMC - DOI
  77. Tang JY et al (2011) Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women’s health initiative randomized controlled trial. J Clin Oncol 29(22):3078–3084 - PubMed - PMC - DOI
  78. Vasilovici AF et al (2019) Vitamin D receptor polymorphisms and melanoma. Oncol Lett 17(5):4162–4169 - PubMed
  79. Birke M et al (2020) Association of vitamin D receptor gene polymorphisms with melanoma risk: a meta-analysis and systematic review. Anticancer Res 40(2):583–595 - PubMed - DOI
  80. Samant H, Amiri HS, Zibari GB (2021) Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management. J Gastrointest Oncol 12(Suppl 2):S361–S373 - PubMed - PMC - DOI
  81. McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(Suppl 1):4–13 - PubMed - DOI
  82. Provvisiero DP et al (2019) Vitamin D reverts resistance to the mTOR inhibitor everolimus in hepatocellular carcinoma through the activation of a miR-375/oncogenes circuit. Sci Rep 9(1):11695 - PubMed - PMC - DOI
  83. Huang J et al (2016) 1,25(OH)2D3 inhibits the progression of hepatocellular carcinoma via downregulating HDAC2 and upregulating P21(WAFI/CIP1). Mol Med Rep 13(2):1373–1380 - PubMed - DOI
  84. Hamilton JP et al (2014) Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma. Hepatol Res 44(13):1357–1366 - PubMed - PMC - DOI
  85. Chen J et al (2016) Vitamin D deficiency promotes liver tumor growth in transforming growth factor-beta/Smad3-deficient mice through Wnt and toll-like receptor 7 pathway modulation. Sci Rep 6:30217 - PubMed - PMC - DOI
  86. Gilliland DG, Jordan CT, Felix CA (2004) The molecular basis of leukemia. Hematol Am Soc Hematol Educ Progr 2004(1):80–97 - DOI
  87. Lee HJ et al (2014) Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. cancer 120(4):521–529 - PubMed - DOI
  88. Jackmann N et al (2020) Vitamin D status in children with leukemia, its predictors, and association with outcome. Pediatr Blood cancer 67(4):e28163 - PubMed - DOI
  89. Wang J et al (2008) Vitamin D3 induces autophagy of human myeloid leukemia cells. J Biol Chem 283(37):25596–25605 - PubMed - DOI
  90. Kricker A et al (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J cancer 122(1):144–154 - PubMed - DOI
  91. Shanafelt TD et al (2011) Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood 117(5):1492–1498 - PubMed - PMC - DOI
  92. Gediz F et al (2020) A possible connection between circulating 25-hydroxy-vitamin D and molecular response in chronic myeloid leukemia. Bratisl Lek Listy 121(5):366–369 - PubMed
  93. Lokeshwar BL et al (1999) Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089. cancer Epidemiol Biomarkers Prev 8(3):241–248 - PubMed
  94. Chen Y et al (2013) Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein. J Biol Chem 288(27):19450–19458 - PubMed - PMC - DOI
  95. Kristal AR et al (2014) Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E cancer Prevention Trial. cancer Epidemiol Biomarkers Prev 23(8):1494–1504 - PubMed - PMC - DOI
  96. Jiang X et al (2019) Circulating vitamin D concentrations and risk of breast and prostate cancer: a Mendelian randomization study. Int J Epidemiol 48(5):1416–1424 - PubMed - DOI
  97. Albanes D et al (2011) Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study. cancer Epidemiol Biomarkers Prev 20(9):1850–1860 - PubMed - PMC - DOI
  98. Protiva P et al (2016) Calcium and 1,25-dihydroxyvitamin D3 modulate genes of immune and inflammatory pathways in the human colon: a human crossover trial. Am J Clin Nutr 103(5):1224–1231 - PubMed - PMC - DOI
  99. Field S, Newton-Bishop JA (2011) Melanoma and vitamin D. Mol Oncol 5(2):197–214 - PubMed - PMC - DOI

VitaminDWiki – Cancer category contains:


Cancers get less Vitamin D when there is a poor Vitamin D Receptor

Vitamin D and Cancer - Jan 2024        
236 visitors, last modified 02 Feb, 2024,
(Cached) Printer Friendly Follow this page for updates

Attached files

ID Name Comment Uploaded Size Downloads
20741 Role.png admin 02 Feb, 2024 87.71 Kb 76